Questions About Cancer? 1-800-4-CANCER
  • View entire document
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Skin Cancer Screening (PDQ®)

Changes to This Summary (04/02/2015)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Description of the Evidence

Added text to state that between 1998 and 2007, a 2.5% relative yearly incidence increase in pediatric melanoma was observed in Surveillance, Epidemiology, and End Results Program databases; during that time, the average annual incidence in this group was exceptionally low, however, and may have resulted in spurious tends; nevertheless, similar trends have been seen in Sweden. Also add text to state that in the U.S. study of pediatric melanoma, nearly one-half of the patients had local disease, and nearly one-half of the patients had disease with a thickness of less than one millimeter; given that mortality from pediatric melanoma had been fairly stable during those years, it is likely that the increase in incidence can be explained, at least in part, by overdiagnosis (cited Austin et al. as reference 8 and Lewis as reference 9).

This summary is written and maintained by the PDQ Screening and Prevention Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ NCI's Comprehensive Cancer Database pages.

  • Updated: April 2, 2015